360 related articles for article (PubMed ID: 10356322)
1. Interaction of interferon regulatory factor-1 and nuclear factor kappaB during activation of inducible nitric oxide synthase transcription.
Saura M; Zaragoza C; Bao C; McMillan A; Lowenstein CJ
J Mol Biol; 1999 Jun; 289(3):459-71. PubMed ID: 10356322
[TBL] [Abstract][Full Text] [Related]
2. Tumour necrosis factor-alpha and interferon-gamma synergistically activate the RANTES promoter through nuclear factor kappaB and interferon regulatory factor 1 (IRF-1) transcription factors.
Lee AH; Hong JH; Seo YS
Biochem J; 2000 Aug; 350 Pt 1(Pt 1):131-8. PubMed ID: 10926836
[TBL] [Abstract][Full Text] [Related]
3. Interferon (IFN)-gamma and Herpes simplex virus/tumor necrosis factor-alpha synergistically induce nitric oxide synthase 2 in macrophages through cooperative action of nuclear factor-kappa B and IFN regulatory factor-1.
Paludan SR; Malmgaard L; Ellermann-Eriksen S; Boscá L; Mogensen SC
Eur Cytokine Netw; 2001; 12(2):297-308. PubMed ID: 11399519
[TBL] [Abstract][Full Text] [Related]
4. Synergistic expression of inducible nitric oxide synthase by phorbol ester and interferon-gamma is mediated through NF-kappaB and ERK in microglial cells.
Han IO; Kim HS; Kim HC; Joe EH; Kim WK
J Neurosci Res; 2003 Sep; 73(5):659-69. PubMed ID: 12929133
[TBL] [Abstract][Full Text] [Related]
5. Requirement of tumor necrosis factor alpha and nuclear factor-kappaB in the induction by IFN-gamma of inducible nitric oxide synthase in macrophages.
Vila-del Sol V; Díaz-Muñoz MD; Fresno M
J Leukoc Biol; 2007 Jan; 81(1):272-83. PubMed ID: 17035338
[TBL] [Abstract][Full Text] [Related]
6. Induction of transcription factor interferon regulatory factor-1 by interferon-gamma (IFN gamma) and tumor necrosis factor-alpha (TNF alpha) in FRTL-5 cells.
Mori K; Stone S; Khaodhiar L; Braverman LE; DeVito WJ
J Cell Biochem; 1999 Aug; 74(2):211-9. PubMed ID: 10404391
[TBL] [Abstract][Full Text] [Related]
7. The role of STAT1/IRF-1 on synergistic ROS production and loss of mitochondrial transmembrane potential during hepatic cell death induced by LPS/d-GalN.
Lee HJ; Oh YK; Rhee M; Lim JY; Hwang JY; Park YS; Kwon Y; Choi KH; Jo I; Park SI; Gao B; Kim WH
J Mol Biol; 2007 Jun; 369(4):967-84. PubMed ID: 17475277
[TBL] [Abstract][Full Text] [Related]
8. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation.
Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
J Immunol; 1999 Apr; 162(8):4685-96. PubMed ID: 10202009
[TBL] [Abstract][Full Text] [Related]
9. Peroxide-mediated chromatin remodelling of a nuclear factor kappa B site in the mouse inducible nitric oxide synthase promoter.
Wei J; Guo H; Gao C; Kuo PC
Biochem J; 2004 Feb; 377(Pt 3):809-18. PubMed ID: 14599292
[TBL] [Abstract][Full Text] [Related]
10. 16-kDa prolactin down-regulates inducible nitric oxide synthase expression through inhibition of the signal transducer and activator of transcription 1/IFN regulatory factor-1 pathway.
Lee SH; Nishino M; Mazumdar T; Garcia GE; Galfione M; Lee FL; Lee CL; Liang A; Kim J; Feng L; Eissa NT; Lin SH; Yu-Lee LY
Cancer Res; 2005 Sep; 65(17):7984-92. PubMed ID: 16140971
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoids inhibit the induction of nitric oxide synthase II by down-regulating cytokine-induced activity of transcription factor nuclear factor-kappa B.
Kleinert H; Euchenhofer C; Ihrig-Biedert I; Förstermann U
Mol Pharmacol; 1996 Jan; 49(1):15-21. PubMed ID: 8569701
[TBL] [Abstract][Full Text] [Related]
12. Regulation by cytokines of the inducible nitric oxide synthase promoter in insulin-producing cells.
Darville MI; Eizirik DL
Diabetologia; 1998 Sep; 41(9):1101-8. PubMed ID: 9754830
[TBL] [Abstract][Full Text] [Related]
13. Complementary roles of tumor necrosis factor alpha and interferon gamma in inducible microglial nitric oxide generation.
Mir M; Tolosa L; Asensio VJ; Lladó J; Olmos G
J Neuroimmunol; 2008 Nov; 204(1-2):101-9. PubMed ID: 18703234
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide and tumor necrosis factor-alpha production by oleanolic acid via nuclear factor-kappaB activation in macrophages.
Choi CY; You HJ; Jeong HG
Biochem Biophys Res Commun; 2001 Oct; 288(1):49-55. PubMed ID: 11594750
[TBL] [Abstract][Full Text] [Related]
15. Conserved high-affinity NF-kappa B binding site in the interferon regulatory factor-1 promoter is not occupied by NF-kappa B in vivo and is transcriptionally inactive.
Rein T; Schreck R; Willenbrink W; Neubert WJ; Zorbas H; Bäuerle PA
J Inflamm; 1995; 45(4):269-82. PubMed ID: 8867671
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of lipopolysaccharide-induced inducible nitric oxide synthase expression by a novel compound, mercaptopyrazine, through suppression of nuclear factor-kappaB binding to DNA.
Lim S; Kang KW; Park SY; Kim SI; Choi YS; Kim ND; Lee KU; Lee HK; Pak YK
Biochem Pharmacol; 2004 Aug; 68(4):719-28. PubMed ID: 15276079
[TBL] [Abstract][Full Text] [Related]
17. Requirement for STAT1 in LPS-induced gene expression in macrophages.
Ohmori Y; Hamilton TA
J Leukoc Biol; 2001 Apr; 69(4):598-604. PubMed ID: 11310846
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of inducible nitric-oxide synthase expression by (5R)-5-hydroxytriptolide in interferon-gamma- and bacterial lipopolysaccharide-stimulated macrophages.
Zhou R; Zheng SX; Tang W; He PL; Li XY; Yang YF; Li YC; Geng JG; Zuo JP
J Pharmacol Exp Ther; 2006 Jan; 316(1):121-8. PubMed ID: 16166270
[TBL] [Abstract][Full Text] [Related]
19. Multinutrient undernutrition dysregulates the resident macrophage proinflammatory cytokine network, nuclear factor-kappaB activation, and nitric oxide production.
Anstead GM; Chandrasekar B; Zhang Q; Melby PC
J Leukoc Biol; 2003 Dec; 74(6):982-91. PubMed ID: 12960263
[TBL] [Abstract][Full Text] [Related]
20. NF-kappa B activation contributes to indoleamine dioxygenase transcriptional synergy induced by IFN-gamma and tumor necrosis factor-alpha.
Robinson CM; Hale PT; Carlin JM
Cytokine; 2006 Jul; 35(1-2):53-61. PubMed ID: 16931033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
